Immunoassays – Products
CHO Host Cell Protein – HCPQuant ELISA Kit
The HCPQuant CHO ELISA kit provides 89% coverage of host cell protein (HCP) impurities from CHO cell lysates. Use this kit to confidently quantitate and characterize HCPs in process-derived samples harvested from CHO supernatant.
ImageQuant™ Western Blot Imaging Systems
Use compact ImageQuant™ biomolecular imagers for sensitive, accurate chemiluminescence and fluorescence detection of Western blots, gels, and plates. Well suited for multi-use labs. If you work in a regulated environment, choose an GxP module to support your electronic data management.
Amersham™ HCPQuant CHO HCP ELISA Kits
In collaboration with Cytiva Life Sciences, Rockland has developed and extensively validated the Amersham HCPQuant CHO HCP ELISA Kits to provide industry professionals a complete solution that supports host cell protein risk mitigation, meeting industry standards for specificity and sensitivity.
Medix Biochemica Broadens its Capabilities in Diagnostic Base Matrices Through the Acquisition of Bioresource Technology
Medix Biochemica has acquired 100 percent of the shares of Bioresource Technology to broaden its base matrix capabilities and further strengthen its local presence in the US market.
Atik Cameras Launches ChemiMOS; A New Cooled CMOS Camera, Optimized for Long Exposure Imaging
Atik Cameras has launched ChemiMOS, the first in a series of high-resolution complementary metal oxide semiconductor (CMOS) cameras.
Rapid Extraction of Top-Quality Purified RNA
Extraction and purification of RNA is required for numerous downstream molecular biology applications such as RT-PCR, qPCR, Western blotting and RNA amplification.
Discovery Solutions for Cell and Gene Therapy
As a leading manufacturer of recombinant proteins and other critical reagents to support the development of biomedicine, ACROBiosystems is proud to stand by you in the CGT journey.
Bio-Rad Introduces Anti-Cemiplimab Antibodies
Bio-Rad Laboratories, Inc. has introduced a range of antibodies that are specific to cemiplimab (Libtayo) and inhibit the binding of the drug to its target, human programmed death receptor-1 (PD-1).
Ella™ - Your Next Generation Automated ELISA
Maximize the return on your immunoassay investment with fully automated Simple Plex™ assays on Ella. With over 200 fully validated assays to choose from, you can get highly reproducible validated assay data, with no manual steps, in just 90 minutes.
Improving Efficiency in Drug Discovery and Preclinical Development
Creating and bringing new drugs to the market can bring huge productivity challenges as the already complex drug development process becomes lengthier and more expensive.